Motivational Interviewing and Medication Review in Coronary Heart Disease (MIMeRiC)
Coronary Heart Disease
About this trial
This is an interventional supportive care trial for Coronary Heart Disease
Eligibility Criteria
Inclusion Criteria:
- Admitted for angiography
- Verified Coronary Artery Disease (ICD-10 I20-I21)
- Planned for follow up at the out-patient clinic (standard treatment)
- Swedish speaking
Exclusion Criteria:
- Cognitive impairment or any othe condition making interview or phone calls impossible.
- Non-participation in the standard follow-up
- Prior participation in this study
Sites / Locations
- Kalmar County Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
MI and Medication review
Standard treatment
The intervention starts three months post-discharge after the standard treatment at the out-patients clinic. A medication review focused on cardiovascular drugs, and a counselling session with a clinical pharmacist using Motivational Interviewing (MI)-approach, and a follow-up phone call two weeks later. For patients with negative beliefs about medicines, three additional MI-sessions in clinic or by phone are planned together with the patient. Irrespective of beliefs the intervention ends with a second medication review and counselling session, which is coordinated with the 12-months post-discharge follow-up in primary care.
Standard treatment at the cardiology out-patient clinic. Follow-up by nurse after two weeks and by physician after two months.